NorthSea Therapeutics

Summary

Seedtable Score

69

Locations

• Amsterdam

Company Size

• 11 - 51

Last Stage Round

• Series C

Industry

• Biotech
• Health Tech

Insights

NorthSea Therapeutics, based in Amsterdam, shows promise in the specialized field of treating inflammatory, metabolic, and liver diseases with innovative therapeutic drugs. Their focus on novel treatments addresses a significant market gap where conventional pharmaceuticals and lifestyle changes often fall short. Supported by investors like Sofinnova Partners, Novo A/S, Forbion Capital Partners, and Ysios Capital, the company is well-positioned to develop and commercialize groundbreaking therapies. Their B2B model allows for efficient collaboration with healthcare providers and biotech firms, potentially leading to rapid market adoption and sustained growth.

• Series C (2021-01-01) $80.0M

---

• Series B (2020-01-01) $40.0M

---

• Series A (2017-12-01) $27.0M

---

Investors

• Sofinnova Partners Series C

---

• Sofinnova Partners Series C

---

• Sofinnova Partners Series C

---

• Sofinnova Partners Series C

---

• Forbion Capital Partners Series C

---

• Forbion Capital Partners Series C

---

• Novo A/S Series C

---

• Novo A/S Series C

---

• Ysios Capital Series C

---

• Sofinnova Partners Series B

---

• Sofinnova Partners Series B

---

• Sofinnova Partners Series B

---

• Sofinnova Partners Series B

---

• Forbion Capital Partners Series B

---

• Forbion Capital Partners Series B

---

• Novo A/S Series B

---

• Novo A/S Series B

---

• Forbion Capital Partners Series A

---

• Forbion Capital Partners Series A

---

• Novo A/S Series A

---

• Novo A/S Series A

---

Full Company Profile

Access details of the company management, and other intelligence on this company by registering for Seedtable

---